
Sign up to save your podcasts
Or


In this episode we dive into Medipharm Lab's Q1 2020 results which greatly disappointed the market
- What's going on with LABS? Why did it have such a drop off in revenue?
- How does it compare to Valens?
- Examining their recent $37M financing (good and bad)
- How the slow 2.0 rollout is hurting the extraction industry
- Why 2019 was such a good year for LABS - will it recover?
- How will the extraction landscape look in the next 1-3 years?
By CIN Podcast4.6
6767 ratings
In this episode we dive into Medipharm Lab's Q1 2020 results which greatly disappointed the market
- What's going on with LABS? Why did it have such a drop off in revenue?
- How does it compare to Valens?
- Examining their recent $37M financing (good and bad)
- How the slow 2.0 rollout is hurting the extraction industry
- Why 2019 was such a good year for LABS - will it recover?
- How will the extraction landscape look in the next 1-3 years?

30,184 Listeners

3,243 Listeners

26,388 Listeners

9,757 Listeners

1,842 Listeners

54 Listeners

2,160 Listeners

6,101 Listeners

10,235 Listeners

109 Listeners

8 Listeners

3 Listeners

10 Listeners

16 Listeners

1,478 Listeners